Genetic engineering of platelets to neutralize circulating tumor cells

Journal of Controlled Release

Volumn 228, Issue , 2016, Pages 38-47

  Li, Jiahe ^a,c   Sharkey, Charles C ^a   Wun, Brittany ^a   Liesveld, Jane L ^b   King, Michael R ^a  

^a School of Chemical and Molecular Engineering   (United States)

^b UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

^c USA   (United States)

Author keywords

Cancer therapy; Circulating tumor cells; Metastasis; Platelet

Indexed keywords

BLOOD; CARDIOVASCULAR SYSTEM; CELL DEATH; CELL ENGINEERING; CELLS; CYTOLOGY; DISEASES; GENETIC ENGINEERING; PATHOLOGY; TUMORS;

CANCER THERAPY; CIRCULATING TUMOR CELLS; CIRCULATORY SYSTEMS; EXPERIMENTAL EVIDENCE; GENETICALLY MODIFIED; METASTASIS; PLATELET ACTIVATION; TUMOR NECROSIS FACTOR-RELATED APOPTOSIS-INDUCING LIGANDS;

PLATELETS;

CYTOKINE; RECOMBINANT TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND;

ANIMAL CELL; ANIMAL MODEL; APOPTOSIS; ARTICLE; CANCER CELL; CELL DIFFERENTIATION; CELL INTERACTION; CELL KILLING; CELL PROLIFERATION; CIRCULATING TUMOR CELL; CONTROLLED STUDY; DNA MODIFICATION; GENE EXPRESSION; GENETIC ENGINEERING; HUMAN; HUMAN CELL; IN VITRO STUDY; MALE; METASTASIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROSTATE CANCER; THROMBOCYTE; TUMOR XENOGRAFT; ANIMAL; C57BL MOUSE; CELL CULTURE; CYTOLOGY; GENETIC TRANSDUCTION; GENETICS; HEMATOPOIETIC STEM CELL; MEGAKARYOCYTE; METABOLISM; NEOPLASM METASTASIS; PATHOLOGY; PROCEDURES; PROSTATE; PROSTATIC NEOPLASMS; TRANSPLANTATION; TUMOR CELL LINE; TUMOR EMBOLISM;

ANIMALS; BLOOD PLATELETS; CELL DIFFERENTIATION; CELL LINE, TUMOR; CELLS, CULTURED; GENE EXPRESSION; GENETIC ENGINEERING; HEMATOPOIETIC STEM CELLS; HUMANS; MALE; MEGAKARYOCYTES; MICE, INBRED C57BL; NEOPLASM METASTASIS; NEOPLASTIC CELLS, CIRCULATING; PROSTATE; PROSTATIC NEOPLASMS; TNF-RELATED APOPTOSIS-INDUCING LIGAND; TRANSDUCTION, GENETIC;

EID: 84960443459     PISSN: 01683659     EISSN: 18734995     Source Type: Journal    
DOI: 10.1016/j.jconrel.2016.02.036     Document Type: Article

References (57)

1. J. Li, and et al. Nanobiotechnology for the therapeutic targeting of cancer cells in blood Cell. Mol. Bioeng. 2015 1 14
2. S. Valastyan, and R.A. Weinberg Tumor metastasis: molecular insights and evolving paradigms Cell 147 2 2011 275 292
3. P. Mehlen, and A. Puisieux Metastasis: a question of life or death Nat. Rev. Cancer 6 6 2006 449 458
4. A.F. Chambers, A.C. Groom, and I.C. MacDonald Dissemination and growth of cancer cells in metastatic sites Nat. Rev. Cancer 2 8 2002 563 572
5. P.E. Massa, and et al. Salmonella engineered to express CD20-targeting antibodies and a drug-converting enzyme can eradicate human lymphomas Blood 122 5 2013 705 714
6. D.W. Stuckey, and K. Shah Stem cell-based therapies for cancer treatment: separating hope from hype Nat. Rev. Cancer 14 10 2014 683 691
7. T.M. Kauer, and et al. Encapsulated therapeutic stem cells implanted in the tumor resection cavity induce cell death in gliomas Nat. Neurosci. 15 2 2012 197 204
8. I.V. Balyasnikova, and et al. Intranasal delivery of mesenchymal stem cells significantly extends survival of irradiated mice with experimental brain tumors Mol. Ther. 22 1 2014 140 148
9. A. Nakamizo, and et al. Human bone marrow-derived mesenchymal stem cells in the treatment of gliomas Cancer Res. 65 8 2005 3307 3318
10. S.C. Liu, and et al. Anticancer efficacy of systemically delivered anaerobic bacteria as gene therapy vectors targeting tumor hypoxia/necrosis Gene Ther. 9 4 2002 291 296
11. M. Labelle, and R.O. Hynes The initial hours of metastasis: the importance of cooperative host-tumor cell interactions during hematogenous dissemination Cancer Discov. 2 12 2012 1091 1099
12. L.J. Gay, and B. Felding-Habermann Contribution of platelets to tumour metastasis Nat. Rev. Cancer 11 2 2011 123 134
13. M.E. Daly Determinants of platelet count in humans Haematol. Hematol. J. 96 1 2011 10 13
14. L. Borsig, and et al. Heparin and cancer revisited: mechanistic connections involving platelets, P-selectin, carcinoma mucins, and tumor metastasis Proc. Natl. Acad. Sci. U. S. A. 98 6 2001 3352 3357
15. B. Nieswandt, and et al. Lysis of tumor cells by natural killer cells in mice is impeded by platelets Cancer Res. 59 6 1999 1295 1300
16. L. Moretta, and A. Moretta Unravelling natural killer cell function: triggering and inhibitory human NK receptors EMBO J. 23 2 2004 255 259
17. T. Placke, and et al. Platelet-derived MHC class I confers a pseudonormal phenotype to cancer cells that subverts the antitumor reactivity of natural killer immune cells Cancer Res. 72 2 2012 440 448
18. W. Zhang, and et al. A humanized single-chain antibody against beta 3 integrin inhibits pulmonary metastasis by preferentially fragmenting activated platelets in the tumor microenvironment Blood 120 14 2012 2889 2898
19. A. Amirkhosravi, and et al. Assessment of Anti-Metastatic Effects of Anticoagulant and Antiplatelet Agents Using Animal Models of Experimental Lung Metastasis second ed. Anticoagulants, Antiplatelets, and Thrombolytics 663 2010 241 259
20. M. Hejna, M. Raderer, and C.C. Zielinski Inhibition of metastases by anticoagulants J. Natl. Cancer Inst. 91 1 1999 22 36
21. S. Wang The promise of cancer therapeutics targeting the TNF-related apoptosis-inducing ligand and TRAIL receptor pathway Oncogene 27 48 2008 6207 6215
22. J. Li, C.C. Sharkey, and M.R. King Piperlongumine and immune cytokine TRAIL synergize to promote tumor death Sci. Rep. 5 2015 9987
23. M.J. Michell, and et al. TRAIL-coated leukocytes that kill cancer cells Proc. Natl. Acad. Sci. U. S. A. 11 3 2013 930 935
24. J. Li, and et al. Targeted drug delivery to circulating tumor cells via platelet membrane-functionalized particles Biomaterials 76 2015 52 65
25. Q. Leng, and et al. TRAIL-secreting mesenchymal stem cells promote apoptosis in heat-shock-treated liver cancer cells and inhibit tumor growth in nude mice Gene Ther. 21 3 2013 317 327
26. M.R. Loebinger, and et al. Mesenchymal stem cell delivery of TRAIL can eliminate metastatic cancer Cancer Res. 69 10 2009 4134 4142
27. H.G. Kopp, T. Placke, and H.R. Salih Platelet-derived transforming growth factor-beta down-regulates NKG2D thereby inhibiting natural killer cell antitumor reactivity Cancer Res. 69 19 2009 7775 7783
28. K.W. Wagner, and et al. Death-receptor O-glycosylation controls tumor-cell sensitivity to the proapoptotic ligand Apo2L/TRAIL Nat. Med. 13 9 2007 1070 1077
29. Li, J. and M.R. King, Adhesion receptors as therapeutic targets for circulating tumor cells. Front. Oncol., 2012. 2: p. 79.
30. L.E. Phipps, S. Hino, and R.J. Muschel Targeting cell spreading: a method of sensitizing metastatic tumor cells to TRAIL-induced apoptosis Mol. Cancer Res. 9 3 2011 249 258
31. J. Fang, and et al. Platelet gene therapy improves hemostatic function for integrin alphaIIbbeta3-deficient dogs Proc. Natl. Acad. Sci. U. S. A. 108 23 2011 9583 9588
32. Q. Shi, and et al. Lentivirus-mediated platelet-derived factor VIII gene therapy in murine haemophilia A J. Thromb. Haemost. 5 2 2007 352 361
33. E.L. Kuether, and et al. Lentivirus-mediated platelet gene therapy of murine hemophilia A with pre-existing anti-factor VIII immunity J. Thromb. Haemost. 10 8 2012 1570 1580
34. A. Biffi, and et al. Lentiviral hematopoietic stem cell gene therapy benefits metachromatic leukodystrophy Science 341 6148 2013 1233158
35. A. Aiuti, and et al. Lentiviral hematopoietic stem cell gene therapy in patients with Wiskott-Aldrich syndrome Science 341 6148 2013 1233151
36. C. Lois, and et al. Germline transmission and tissue-specific expression of transgenes delivered by lentiviral vectors Science 295 5556 2002 868 872
37. J. Li, and et al. Human fucosyltransferase 6 enables prostate cancer metastasis to bone Br. J. Cancer 109 12 2013 3014 3022
38. D.A. Wilcox, and et al. Integrin alphaIIb promoter-targeted expression of gene products in megakaryocytes derived from retrovirus-transduced human hematopoietic cells Proc. Natl. Acad. Sci. U. S. A. 96 17 1999 9654 9659
39. A.M. Fong, and S.A. Santoro Transcriptional regulation of alpha IIb integrin gene expression during megakaryocytic differentiation of K562 cells. Role of a silencer element J. Biol. Chem. 269 28 1994 18441 18447
40. M.M. Zutter, and et al. Regulation of alpha 2 integrin gene expression in cells with megakaryocytic features: a common theme of three necessary elements Blood 86 8 1995 3006 3014
41. P.R. Lev, and et al. Production of functional platelet-like particles by the megakaryoblastic DAMI cell line provides a model for platelet biogenesis Platelets 22 1 2011 28 38
42. K. Takeuchi, and et al. Production of platelet-like particles by a human megakaryoblastic leukemia cell line (MEG-01) Exp. Cell Res. 193 1 1991 223 226
43. J. Sahler, and et al. A novel method for overexpression of peroxisome proliferator-activated receptor-gamma in megakaryocyte and platelet microparticles achieves transcellular signaling J. Thromb. Haemost. 10 12 2012 2563 2572
44. C. Criscitiello, and et al. Understanding the biology of triple-negative breast cancer Ann. Oncol. 23 2012 13 18
45. J. Sturge, M.P. Caley, and J. Waxman Bone metastasis in prostate cancer: emerging therapeutic strategies Nat. Rev. Clin. Oncol. 8 6 2011 357 368
46. N. Corazza, and et al. TRAIL and immunity: more than a license to kill tumor cells Cell Death Differ. 11 2004 S122 S125
47. L.S. Elting, and et al. Incidence, cost, and outcomes of bleeding and chemotherapy dose modification among solid tumor patients with chemotherapy-induced thrombocytopenia J. Clin. Oncol. 19 4 2001 1137 1146
48. R.J. Benjamin, and K.C. Anderson What is the proper threshold for platelet transfusion in patients with chemotherapy-induced thrombocytopenia? Crit. Rev. Oncol. Hematol. 42 2 2002 163 171
49. L. Erpenbeck, and M.P. Schon Deadly allies: the fatal interplay between platelets and metastasizing cancer cells Blood 115 17 2010 3427 3436
50. J. Li, and et al. Targeted drug delivery to circulating tumor cells via platelet membrane-functionalized particles Biomaterials 76 2016 52 65
51. C.L. Modery-Pawlowski, and et al. A platelet-mimetic paradigm for metastasis-targeted nanomedicine platforms Biomacromolecules 14 3 2013 910 919
52. Q. Hu, and et al. Anticancer platelet-mimicking nanovehicles Adv. Mater. 27 44 2015 7043 7050
53. O. Ringden Allogeneic bone marrow transplantation for hematological malignancies - controversies and recent advances Acta Oncol. 36 6 1997 549 564
54. R. Fuentes, and et al. Infusion of mature megakaryocytes into mice yields functional platelets J. Clin. Investig. 120 11 2010 3917 3922
55. M.P. Lambert, and et al. Challenges and promises for the development of donor-independent platelet transfusions Blood 121 17 2013 3319 3324
56. M. Kawamoto, and et al. A novel transferrin receptor-targeted hybrid peptide disintegrates cancer cell membrane to induce rapid killing of cancer cells BMC Cancer 11 2011
57. D.D. Wu, and et al. Peptide-based cancer therapy: opportunity and challenge Cancer Lett. 351 1 2014 13 22